HuGE Literature Finder
Records
1
-
10
| NUDT15 R139C Variants Increase the Risk of Azathioprine-Induced Leukopenia in Chinese Autoimmune Patients. Frontiers in pharmacology 2018 9 460. Fei Xiang, Shu Qing, Zhu Huaijun, Hua Bingzhu, Wang Shiying, Guo Ling, Fang Yun, Ge Weiho |
| A Simple Method for TPMT and ITPA Genotyping Using Multiplex HRMA for Patients Treated with Thiopurine Drugs. Molecular diagnosis & therapy 2016 Oct 20 (5): 493-9. Skrzypczak-Zielinska Marzena, Borun Pawel, Bartkowiak-Kaczmarek Anna, Zakerska-Banaszak Oliwia, Walczak Michal, Dobrowolska Agnieszka, Kurzawski Mateusz, Waszak Malgorzata, Lipinski Daniel, Plawski Andrzej, Slomski Rysza |
Polymorphic variation in TPMT is the principal determinant of TPMT phenotype: A meta-analysis of three genome-wide association studies.
Clinical pharmacology and therapeutics 2016 Oct . Tamm Riin, Mägi Reedik, Tremmel Roman, Winter Stefan, Mihailov Evelin, Smid Alenka, Möricke Anja, Klein Kathrin, Schrappe Martin, Stanulla Martin, Houlston Richard, Weinshilboum Richard, Mlinari? Raš?an Irena, Metspalu Andres, Milani Lili, Schwab Matthias, Schaeffeler El |
| Risk factors for serious adverse effects of thiopurines in patients with Crohn's disease. Current drug safety 2013 Jul 8 (3): 181-5. Mazor Yoav, Koifman Eduard, Elkin Hela, Chowers Yehuda, Krivoy Norberto, Karban Amir, Efrati Ed |
| The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases. Bratislavské lekárske listy 2013 114 (4): 199-205. Hlavaty T, Batovsky M, Balakova D, Pav I, Celec P, Gregus M, Zakuciova M, Hlista M, Horakova M, Desatova B, Koller T, Toth J, Kadasi L, Huorka M, |
| High-resolution melting analysis of the TPMT gene: a study in the Polish population. Genetic testing and molecular biomarkers 2012 Dec . Skrzypczak-Zielinska M, Borun P, Milanowska K, Jakubowska-Burek L, Zakerska O, Dobrowolska-Zachwieja A, Plawski A, Froster UG, Szalata M, Slomski R |
| High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease. European journal of internal medicine 2012 Apr 23 (3): 273-7. Larussa Tiziana, Suraci Evelina, Lentini Margherita, Nazionale Immacolata, Gallo Luigia, Abenavoli Ludovico, Imeneo Maria, Costanzo Francesco Saverio, Cuda Giovanni, Luzza Frances |
| A pharmacogenetics study of TPMT and ITPA genes detects a relationship with side effects and clinical response in patients with inflammatory bowel disease receiving Azathioprine. Journal of gastrointestinal and liver diseases : JGLD 2011 Sep 20 (3): 247-53. Zabala-Fernández William, Barreiro-de Acosta Manuel, Echarri Ana, Carpio Daniel, Lorenzo Aurelio, Castro Javier, Martínez-Ares David, Pereira Santos, Martin-Granizo Ignacio, Corton Marta, Carracedo Angel, Barros Francis |
| Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism. Pharmacogenetics 2002 Aug 12 (6): 429-36. Schwab Matthias, Schäffeler Elke, Marx Claudia, Fischer Christine, Lang Thomas, Behrens Christoph, Gregor Michael, Eichelbaum Michel, Zanger Ulrich M, Kaskas Bernd |
| Allele frequency of thiopurine methyltransferase and inosine triphosphate pyrophosphatase gene polymorphisms in Korean patients with inflammatory bowel diseases. Hepato-gastroenterology 0 56 (90): 421-3. Cheon Jae Hee, Kim Jae Hak, Kim Bo Young, Kim Seung Won, Hong Sung Yi, Eun Chang Soo, Hong Seong Soo, Byeon Jeong-Sik, Kim Tae Il, Han Dong Soo, Yang Suk-Kyun, Lee Kyoung Ryul, Kim Won |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jan 12, 2022
- Content source: